; Sousa, Marisa ; Servidoni, Maria F. ; Vinagre, Adriana M.
; Ramalho, Anabela S. ; Bonadia, Luciana C. ; Felício, Verónica
; Ribeiro, Maria A.
; Uliyakina, Inna
; Marson, Fernando A. ; Kmit, Arthur ; Cardoso, Silvia R.
; Ribeiro, José D. ; Bertuzzo, Carmen S.
; Sousa, Lisete
; Kunzelmann, Karl
; Ribeiro, Antônio F.
; Amaral, Margarida D. | Item type: | Article | ||||
|---|---|---|---|---|---|
| Journal or Publication Title: | PLoS ONE | ||||
| Publisher: | PUBLIC LIBRARY SCIENCE | ||||
| Place of Publication: | SAN FRANCISCO | ||||
| Volume: | 7 | ||||
| Number of Issue or Book Chapter: | 10 | ||||
| Page Range: | e47708 | ||||
| Date: | 2012 | ||||
| Institutions: | Biology, Preclinical Medicine > Institut für Physiologie > Prof. Dr. Karl Kunzelmann | ||||
| Identification Number: |
| ||||
| Keywords: | TRANSMEMBRANE CONDUCTANCE REGULATOR; NASAL POTENTIAL DIFFERENCE; AIRWAY ION-TRANSPORT; PULMONARY-DISEASE; LUNG-FUNCTION; MUTATION; IDENTIFICATION; CONSENSUS; GENOTYPE; GENE; | ||||
| Dewey Decimal Classification: | 500 Science > 570 Life sciences | ||||
| Status: | Published | ||||
| Refereed: | Yes, this version has been refereed | ||||
| Created at the University of Regensburg: | Yes | ||||
| Item ID: | 63269 |
Abstract
Background: Cystic Fibrosis (CF) is caused by similar to 1,900 mutations in the CF transmembrane conductance regulator (CFTR) gene encoding for a cAMP-regulated chloride (Cl-) channel expressed in several epithelia. Clinical features are dominated by respiratory symptoms, but there is variable organ involvement thus causing diagnostic dilemmas, especially for non-classic cases. ...

Abstract
Background: Cystic Fibrosis (CF) is caused by similar to 1,900 mutations in the CF transmembrane conductance regulator (CFTR) gene encoding for a cAMP-regulated chloride (Cl-) channel expressed in several epithelia. Clinical features are dominated by respiratory symptoms, but there is variable organ involvement thus causing diagnostic dilemmas, especially for non-classic cases. Methodology/Principal Findings: To further establish measurement of CFTR function as a sensitive and robust biomarker for diagnosis and prognosis of CF, we herein assessed cholinergic and cAMP-CFTR-mediated Cl- secretion in 524 freshly excised rectal biopsies from 118 individuals, including patients with confirmed CF clinical diagnosis (n = 51), individuals with clinical CF suspicion (n = 49) and age-matched non-CF controls (n = 18). Conclusive measurements were obtained for 96% of cases. Patients with "Classic CF'', presenting earlier onset of symptoms, pancreatic insufficiency, severe lung disease and low Shwachman-Kulczycki scores were found to lack CFTR-mediated Cl- secretion (<5%). Individuals with milder CF disease presented residual CFTR-mediated Cl- secretion (10-57%) and non-CF controls show CFTR-mediated Cl- secretion >= 30-35% and data evidenced good correlations with various clinical parameters. Finally, comparison of these values with those in "CF suspicion'' individuals allowed to confirm CF in 16/49 individuals (33%) and exclude it in 28/49 (57%). Statistical discriminant analyses showed that colonic measurements of CFTR-mediated Cl- secretion are the best discriminator among Classic/Non-Classic CF and non-CF groups. Conclusions/Significance: Determination of CFTR-mediated Cl- secretion in rectal biopsies is demonstrated here to be a sensitive, reproducible and robust predictive biomarker for the diagnosis and prognosis of CF. The method also has very high potential for (pre-) clinical trials of CFTR-modulator therapies.
Metadata last modified: 19 Dec 2024 09:34
Article Level Metrics (PLOS)